[Corrigendum] Catechin ameliorates depressive symptoms in Sprague Dawley rats subjected to chronic unpredictable mild stress by decreasing oxidative stress
Affiliations: Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India, Ecron Acunova Ltd, Karnataka 576104, India, Department of Anatomy, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India
- Published online on: July 7, 2020 https://doi.org/10.3892/br.2020.1326
- Article Number: 19
Copyright : © Rai et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Biomed Rep 11:[Related article:] 79-84, 2019; DOI: 10.3892/br.2019.1226
Subsequently to the publication of the above article, the authors have realized that the text contained certain errors that were not corrected prior to publication. First, in the Materials and methods section on p. 81, left-hand column, in the subsection ‘Assay for antioxidant catalase levels’, on the fourth line, the range of OD values should have been presented as 0.3-0.5, not as 3-5. Secondly, on pp. 82 and 83, in the figure legends for Figs. 1-3, the text should have been written to state: ‘Rats were subjected to CUMS and treated with escitalopram or catechin for 8 weeks.’ (i.e. not ‘catechol from’). Finally, also in the legend for Fig. 3, the subsequent (i.e, third) sentence should have been written as: ‘After 8 weeks animals were sacrificed and the brains were collected for measurement regarding antioxidant levels; catalase and SOD activity, as well as GSH and MDA levels were determined.’
The authors regret that these errors were allowed to enter into their text, and were not corrected prior to publication. The authors also apologize to the readership for any inconvenience caused.